1. Home
  2. CPA vs KYMR Comparison

CPA vs KYMR Comparison

Compare CPA & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Copa Holdings S.A.

CPA

Copa Holdings S.A.

N/A

Current Price

$122.31

Market Cap

5.5B

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$81.65

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPA
KYMR
Founded
1947
2015
Country
Panama
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.8B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
CPA
KYMR
Price
$122.31
$81.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
26
Target Price
$164.29
$108.04
AVG Volume (30 Days)
394.9K
710.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,211,000.00
Revenue This Year
$13.41
$16.05
Revenue Next Year
$7.38
$4.79
P/E Ratio
$9.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$82.54
$19.45
52 Week High
$156.41
$103.00

Technical Indicators

Market Signals
Indicator
CPA
KYMR
Relative Strength Index (RSI) 32.78 47.15
Support Level $122.10 $77.78
Resistance Level $122.76 $95.90
Average True Range (ATR) 5.16 4.43
MACD -2.50 -1.09
Stochastic Oscillator 9.21 14.60

Price Performance

Historical Comparison
CPA
KYMR

About CPA Copa Holdings S.A.

Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama, and domestic and international air transportation for passengers, cargo, and mail with a point-to-point route network through Copa Colombia, a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: